27533082|t|Ligand dependent restoration of human TLR3 signaling and death in p53 mutant cells
27533082|a|Diversity within the p53 transcriptional network can arise from a matrix of changes that include target response element sequences and p53 expression level variations. We previously found that wild type p53 (WT p53) can regulate expression of most innate immune -related Toll-like-receptor genes (TLRs) in human cells, thereby affecting immune responses. Since many tumor-associated p53 mutants exhibit change-of-spectrum transactivation from various p53 targets, we examined the ability of twenty-five p53 mutants to activate endogenous expression of the TLR gene family in p53 null human cancer cell lines following transfection with p53 mutant expression vectors. While many mutants retained the ability to drive TLR expression at WT levels, others exhibited null, limited, or change-of-spectrum transactivation of TLR genes. Using TLR3 signaling as a model, we show that some cancer -associated p53 mutants amplify cytokine, chemokine and apoptotic responses after stimulation by the cognate ligand poly(I:C). Furthermore, restoration of WT p53 activity for loss-of-function p53 mutants by the p53 reactivating drug RITA restored p53 regulation of TLR3 gene expression and enhanced DNA damage-induced apoptosis via TLR3 signaling. Overall, our findings have many implications for understanding the impact of WT and mutant p53 in immunological responses and cancer therapy.
27533082	0	28	Ligand dependent restoration	T170	C0449982
27533082	32	37	human	T016	C0086418
27533082	38	42	TLR3	T028	C1336635
27533082	43	52	signaling	T043	C1154413
27533082	57	62	death	T043	C0007587
27533082	66	69	p53	T028	C0079419
27533082	70	76	mutant	T028	C0678941
27533082	77	82	cells	T025	C0007634
27533082	83	92	Diversity	T080	C1880371
27533082	104	107	p53	T028	C0079419
27533082	108	131	transcriptional network	T044	C1720950
27533082	180	186	target	T169	C1521840
27533082	187	195	response	T032	C0871261
27533082	196	213	element sequences	T086	C0004793
27533082	218	221	p53	T028	C0079419
27533082	222	232	expression	T045	C0017262
27533082	239	249	variations	T070	C0042333
27533082	276	289	wild type p53	T028	C0079419
27533082	291	297	WT p53	T028	C0079419
27533082	303	322	regulate expression	T045	C0017263
27533082	331	344	innate immune	T032	C0020969
27533082	354	378	Toll-like-receptor genes	T028	C0017337
27533082	380	384	TLRs	T028	C0017337
27533082	389	400	human cells	T034	C0427861
27533082	420	436	immune responses	T042	C0301872
27533082	449	465	tumor-associated	T191	C0027651
27533082	466	469	p53	T028	C0079419
27533082	470	477	mutants	T028	C0678941
27533082	486	520	change-of-spectrum transactivation	T045	C0040624
27533082	534	537	p53	T028	C0079419
27533082	586	589	p53	T028	C0079419
27533082	590	597	mutants	T028	C0678941
27533082	601	631	activate endogenous expression	T045	C0017262
27533082	639	654	TLR gene family	T028	C1517488
27533082	658	661	p53	T028	C0079419
27533082	667	672	human	T016	C0086418
27533082	673	690	cancer cell lines	T025	C0085983
27533082	701	713	transfection	T045	C0314641
27533082	719	722	p53	T028	C0079419
27533082	723	729	mutant	T028	C0678941
27533082	730	748	expression vectors	T114	C0599566
27533082	761	768	mutants	T028	C0678941
27533082	799	813	TLR expression	T045	C0017262
27533082	817	826	WT levels	T028	C1883559
27533082	863	897	change-of-spectrum transactivation	T045	C0040624
27533082	901	910	TLR genes	T028	C0017337
27533082	918	922	TLR3	T028	C1336635
27533082	923	932	signaling	T043	C1154413
27533082	938	943	model	T075	C0026339
27533082	963	969	cancer	T191	C0006826
27533082	982	985	p53	T028	C0079419
27533082	986	993	mutants	T028	C0678941
27533082	1002	1010	cytokine	T116,T129	C0079189
27533082	1012	1021	chemokine	T116,T129	C0282554
27533082	1026	1045	apoptotic responses	T040	C1817727
27533082	1071	1085	cognate ligand	T044	C1749457
27533082	1086	1095	poly(I:C)	T114,T121	C0032414
27533082	1110	1121	restoration	T170	C0449982
27533082	1125	1131	WT p53	T028	C0079419
27533082	1162	1165	p53	T028	C0079419
27533082	1166	1173	mutants	T028	C0678941
27533082	1181	1184	p53	T028	C0079419
27533082	1185	1207	reactivating drug RITA	T121	C1254351
27533082	1217	1220	p53	T028	C0079419
27533082	1221	1255	regulation of TLR3 gene expression	T045	C0017263
27533082	1269	1297	DNA damage-induced apoptosis	T043	C0162638
27533082	1302	1306	TLR3	T028	C1336635
27533082	1307	1316	signaling	T043	C1154413
27533082	1395	1397	WT	T028	C0079419
27533082	1402	1408	mutant	T028	C0678941
27533082	1409	1412	p53	T028	C0079419
27533082	1416	1439	immunological responses	T032	C0871261
27533082	1444	1458	cancer therapy	T061	C0920425